This inventor holds 1 USPTO granted patent. Top assignee: Gemvax as. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Stein Sæøe-Larssen: Innovator in Cancer Immunotherapy
Introduction
Stein Sæøe-Larssen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cancer immunotherapy through his innovative research and development of polypeptides.
Latest Patents
Stein holds a patent related to polypeptides, which are crucial in eliciting immune reactions against cancer. His invention includes nucleic acids DNA encoding these polypeptides, methods for generating T lymphocytes capable of recognizing and destroying tumor cells, and pharmaceutical compositions for the treatment, prophylaxis, or diagnosis of cancer. He has 1 patent to his name.
Career Highlights
Stein Sæøe-Larssen is associated with Gemvax AS, a company focused on advancing cancer treatment technologies. His work has been instrumental in developing therapies that harness the body's immune system to combat cancer effectively.
Collaborations
Stein has collaborated with notable colleagues in the field, including Gustav Gaudernack and Mona Møller. Their combined expertise has contributed to the advancement of cancer immunotherapy research.
Conclusion
Stein Sæøe-Larssen's innovative work in cancer immunotherapy highlights the potential of polypeptides in treating cancer. His contributions are paving the way for future advancements in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile